European Biotech Acquisition Corp. (NASDAQ:EBAC) Short Interest UpdateZolmax • about 1 year agoEuropean Biotech Acquisition Corp. (NASDAQ:EBAC Get Rating) was the recipient of a significant growth in short interest in January. As of January 31st, there was short interest totalling 4,000 shares, a growth of 17.6% from the January 15th total of 3,400 shares. Based on an average daily trading ...